The 20 Best Myelofibrosis Doctors Near Me in New Hyde Park, NY

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Advanced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), and Bone Marrow Transplant. Dr. Al is board certified in American Board Of Internal Medicine/Hematology.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jou is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Shams Shakil, MD, PhD, MS, is an attending physician based at the Monter Cancer Center where he specializes in the treatment of patients with benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Shakil is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Shakil maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He earned his medical degree from Chittagong Medical College in Bangladesh, his PhD from Hiroshima University School of Medicine and his MS in Medical Informatics from the Oregon Health and Science University. His fellowship in Hematology/Oncology was completed at Brookdale University Hospital Center. Dr. Shakil has a research background in both surgical oncology and radiation oncology. He is an active member of the American Society of Hematology. Dr. Shakil is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Anemia, Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Vintila is board certified in American Board Of Internal Medicine/Medical Oncology.

Clifton Lee, MD, is an attending physician based at the Monter Cancer Center where he specializes in benign hematology, bleeding disorders and thrombophilia. He maintains an active practice where he focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Lee is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Lee earned his medical degree at the State University of New York at Stony Brook. He trained in internal medicine at Long Island Jewish Medical Center and completed a fellowship in Hematology/Oncology at the University of Medicine and Dentistry of New Jersey. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Anemia, Thrombocytopenia, Factor 11 Deficiency, and Deep Vein Thrombosis. Dr. Lee is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Kit Cheng, MD, is the Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she is committed to the recruitment and education of future generations of physicians. Board certified in Internal Medicine, Hematology and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As an attending physician based at the Monter Cancer Center, Dr. Cheng specializes in breast cancer and gynecology oncology, namely cervical cancer, endometrial cancer, ovarian cancer, uterine cancer and vaginal cancer. She is a principal investigator and sub principal investigator in multiple breast and gynecologic oncology clinical trials. She maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Cheng earned her medical degree at the State University of New York at Buffalo. She trained in Internal Medicine and Hematology/Oncology at North Shore University Hospital where she was also Chief Fellow. Dr. Cheng is an active member of the American Society of Clinical Oncology and is fluent in Cantonese and English. Dr. Cheng is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Cheng is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Francisco Garcia is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Garcia is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Alpha Thalassemia, Alpha Thalassemia X-Linked Intellectual Disability Syndrome, Thalassemia, and Iron Deficiency Anemia.

Tony Cheung is a Hematologist and an Oncologist practicing medicine in Rockville Centre, New York. Dr. Cheung is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. His clinical expertise encompasses Non-Hodgkin Lymphoma, Gastric Lymphoma, Myeloproliferative Neoplasms (MPN), and Paget Disease of the Breast.

Raajit Rampal is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Rampal is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Rampal is currently accepting new patients.

Roni Tamari is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Tamari is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Myelofibrosis, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Colonoscopy. Dr. Tamari is currently accepting new patients.

Ross Levine is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Levine is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Levine is currently accepting new patients.

John Mascarenhas is an Oncologist practicing medicine in New York, New York. Dr. Mascarenhas is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Bone Marrow Aspiration, and Splenectomy. Dr. Mascarenhas is currently accepting new patients.

Marina Kremyanskaya is an Oncologist practicing medicine in New York, New York. Dr. Kremyanskaya is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Splenectomy. Dr. Kremyanskaya is currently accepting new patients.

Ronald Hoffman is an Oncologist practicing medicine in New York, New York. Dr. Hoffman is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Myelofibrosis, Essential Thrombocythemia, Splenectomy, and Bone Marrow Transplant.

Douglas Tremblay is a Hematologist practicing medicine in New York, New York. Dr. Tremblay is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Myelofibrosis, Polycythemia Vera, Bone Marrow Aspiration, and Splenectomy.

Ellen Ritchie is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Ritchie is rated as an Elite provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelofibrosis, Polycythemia Vera, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Ritchie is currently accepting new patients.

Anna Kurzyna is a Hematologist and an Oncologist practicing medicine in New Hyde Park, New York. Dr. Kurzyna is rated as an Experienced provider by MediFind in the treatment of Myelofibrosis. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Hemolytic Crisis, Childhood Iron Deficiency Anemia, Chronic Lymphocytic Leukemia (CLL), and Inflammatory Breast Cancer.